A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects
Clinical trial NCT03163173 · COMPLETED
Trial details
- NCT number
- NCT03163173
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2017-10-13
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.